<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>药融圈 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-04T11:27:24+08:00</updated>
  <subtitle>药融圈PHARNEX汇聚数万医药大咖，得到数千家医药创业者鼎力支持，开展日常专题讲座。致力于成为“专业、前沿、权威、严谨”的医药行业资讯平台，以及项目、技术、工厂、融资、股权投资等资源整合平台。欢迎您关注药融圈，共同碰撞“药”的火花!</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>全球首款早衰症新药获批；同时重金卖出优先审评券</title>
    <updated>2020-12-03T17:54:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-03:/s/i5MVnBdoYF-DLN2-uDfMMg</id>
    <link href="https://mp.weixin.qq.com/s/i5MVnBdoYF-DLN2-uDfMMg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>吸入制剂流量药企：长风科创板辅导上市！</title>
    <updated>2020-12-03T17:54:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-03:/s/K9WWt5ymihffMfcuTulD6w</id>
    <link href="https://mp.weixin.qq.com/s/K9WWt5ymihffMfcuTulD6w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>科创板CRO第一股美迪西与盛世泰科达成基于PROTAC技术的新药研发合作</title>
    <updated>2020-12-03T17:54:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-03:/s/N3q__xMr--Wr2QFoiuKjAw</id>
    <link href="https://mp.weixin.qq.com/s/N3q__xMr--Wr2QFoiuKjAw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【每日药闻】恒瑞医药诺利糖肽注射液将于近期开展临床试验...</title>
    <updated>2020-12-03T17:54:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-03:/s/yS8YEhiwv0MyhE69FBiaEw</id>
    <link href="https://mp.weixin.qq.com/s/yS8YEhiwv0MyhE69FBiaEw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CNS靶点：KCNQ4钾通道结构研究成果</title>
    <updated>2020-12-03T17:54:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-03:/s/SdnZO_TKaeftsEimudbvqQ</id>
    <link href="https://mp.weixin.qq.com/s/SdnZO_TKaeftsEimudbvqQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>新锐|华人创立新型抗体偶联公司完成6200万美元融资</title>
    <updated>2020-12-03T17:54:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-03:/s/DyZvd4dEDngrfuIOKMJ3SQ</id>
    <link href="https://mp.weixin.qq.com/s/DyZvd4dEDngrfuIOKMJ3SQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医药人的圣诞盛宴！行业大咖与您共聚石家庄免费制剂技术会议</title>
    <updated>2020-12-03T17:54:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-03:/s/M9bVGuKymqquqYqLBD8uUg</id>
    <link href="https://mp.weixin.qq.com/s/M9bVGuKymqquqYqLBD8uUg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>上海医药盐酸贝那普利片和盐酸度洛西汀肠溶胶囊通过仿制药一致性评价</title>
    <updated>2020-12-03T17:54:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-03:/s/bWpNSLLMzas0gtjkBlc46g</id>
    <link href="https://mp.weixin.qq.com/s/bWpNSLLMzas0gtjkBlc46g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>全球首款BCL-2新药中国上市，白血病患者福音</title>
    <updated>2020-12-02T19:39:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-02:/s/teanEdLkvjRsZCgMIfZhAw</id>
    <link href="https://mp.weixin.qq.com/s/teanEdLkvjRsZCgMIfZhAw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>流感新药巴洛沙韦有望通过新适应症引起市场关注</title>
    <updated>2020-12-02T19:39:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-02:/s/83Jlj-OHIA-sOQHPcXRFiA</id>
    <link href="https://mp.weixin.qq.com/s/83Jlj-OHIA-sOQHPcXRFiA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>新锐|Atlas孵化哮喘新药公司完成4000万美元A轮融资，开发干粉吸入泛JAK抑制剂</title>
    <updated>2020-12-02T19:39:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-02:/s/n7wqC69g9NljYTLyoptiwQ</id>
    <link href="https://mp.weixin.qq.com/s/n7wqC69g9NljYTLyoptiwQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>同源康医药完成B轮融资，加速推进肿瘤管线</title>
    <updated>2020-12-02T19:39:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-02:/s/_r0Kv02xpD1MaAfXRyBt-Q</id>
    <link href="https://mp.weixin.qq.com/s/_r0Kv02xpD1MaAfXRyBt-Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>中美华世通完成1亿元C+轮融资，强强联合深耕肾病领域</title>
    <updated>2020-12-02T19:39:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-02:/s/VAfpcd4XAZR3E5v1iJq4zg</id>
    <link href="https://mp.weixin.qq.com/s/VAfpcd4XAZR3E5v1iJq4zg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【每日药闻】亚盛医药：APG-115单药或联合APG-2575&#x9;IIa期临床研究获中美两国临床试验许可...</title>
    <updated>2020-12-02T19:39:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-02:/s/M0pWfMIwtq9Apw2c4BqlfQ</id>
    <link href="https://mp.weixin.qq.com/s/M0pWfMIwtq9Apw2c4BqlfQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医药人的圣诞盛宴！行业大咖与您共聚石家庄免费制剂技术会议</title>
    <updated>2020-12-02T19:39:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-02:/s/yKf2P0QLauLResfxCHR_Ew</id>
    <link href="https://mp.weixin.qq.com/s/yKf2P0QLauLResfxCHR_Ew" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药明康德宣布与ViGeneron达成新一代眼科基因疗法产品生产合作</title>
    <updated>2020-12-02T19:39:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-02:/s/FxdwKIm8S54WHzsrFRyEuw</id>
    <link href="https://mp.weixin.qq.com/s/FxdwKIm8S54WHzsrFRyEuw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>大盘点：中国对海外药企，新药授权初露端倪</title>
    <updated>2020-12-01T17:27:23+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-01:/s/0BajPg1--RHJyppruKrn1w</id>
    <link href="https://mp.weixin.qq.com/s/0BajPg1--RHJyppruKrn1w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>铿锵玫瑰--四川协力制药颜值才华兼具的新生代掌门人张弘</title>
    <updated>2020-12-01T17:27:23+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-01:/s/e0Bk0rIBB8FiWXDe-8f09w</id>
    <link href="https://mp.weixin.qq.com/s/e0Bk0rIBB8FiWXDe-8f09w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>肿瘤免疫药效评价适合选用哪些模型？</title>
    <updated>2020-12-01T17:27:23+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-01:/s/DgbGcMURjj-39L3wUKZmpQ</id>
    <link href="https://mp.weixin.qq.com/s/DgbGcMURjj-39L3wUKZmpQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>糖尿病龙头—华东医药进入收获季，两款产品相继获批</title>
    <updated>2020-12-01T17:27:23+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-01:/s/dQ12JqwezoIo8PVEUw2r0Q</id>
    <link href="https://mp.weixin.qq.com/s/dQ12JqwezoIo8PVEUw2r0Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>